Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2alpha receptor

Details for Australian Patent Application No. 2003236751 (hide)

Owner Theratechnologies Inc. Universite de Montreal

Inventors Chemtob, Sylvain; Lubell, William; Peri, Krishna G.; Thouin, Eryk; Polyak, Felix

Agent Pizzeys

Pub. Number AU-B-2003236751

PCT Number PCT/CA03/00903

PCT Pub. Number WO2003/104266

Priority 60/387,424 11.06.02 US

Filing date 11 June 2003

Wipo publication date 22 December 2003

Acceptance publication date 3 February 2011

International Classifications

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/387,424 11.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-B-2003236751

3 February 2011 Application Accepted

  Published as AU-B-2003236751

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003236752-OLED DISPLAY WITH CONTRAST ENHANCING INTERFERENCE MEMBERS

2003236750-Actuated leg prosthesis for above-knee amputees